Avonex-Steroid Azathioprine (ASA) study in patients with relapsing-remitting multiple sclerosis

Trial Profile

Avonex-Steroid Azathioprine (ASA) study in patients with relapsing-remitting multiple sclerosis

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Feb 2016

At a glance

  • Drugs Interferon beta-1a (Primary) ; Azathioprine; Prednisone
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms ASA
  • Most Recent Events

    • 22 Jun 2012 New source identified and integrated: ClinicalTrials.gov record of MRI study (NCT01628315).
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top